benfotiamine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 308 | 22457-89-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Gastrointestinal haemorrhage | 63.25 | 39.38 | 17 | 97 | 73304 | 50531706 |
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Eye movement disorder | 52.72 | 43.19 | 11 | 301 | 7068 | 64491352 |
| Drug interaction | 46.86 | 43.19 | 26 | 286 | 362057 | 64136363 |
| Oculogyric crisis | 43.95 | 43.19 | 8 | 304 | 2530 | 64495890 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A11DA03 | ALIMENTARY TRACT AND METABOLISM VITAMINS VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 Vitamin B1, plain |
| CHEBI has role | CHEBI:22586 | antioxidants |
| CHEBI has role | CHEBI:50267 | protective agents |
| CHEBI has role | CHEBI:50733 | Dietary Supplement |
| CHEBI has role | CHEBI:50847 | Immunologic adjuvant |
| CHEBI has role | CHEBI:72470 | provitamin B1s |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.16 | acidic |
| pKa2 | 6.98 | acidic |
| pKa3 | 7.59 | Basic |
| pKa4 | 0.96 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4028227 | VUID |
| N0000177939 | NUI |
| D01255 | KEGG_DRUG |
| 18891 | RXNORM |
| C0053116 | UMLSCUI |
| CHEBI:41039 | CHEBI |
| BFT | PDB_CHEM_ID |
| CHEMBL3183549 | ChEMBL_ID |
| CHEMBL1491875 | ChEMBL_ID |
| DB11748 | DRUGBANK_ID |
| 1300 | INN_ID |
| Y92OUS2H9B | UNII |
| 2320 | PUBCHEM_CID |
| 23417 | MMSL |
| 005583 | NDDF |
| 4028227 | VANDF |
| 703399007 | SNOMEDCT_US |
| 704989003 | SNOMEDCT_US |
Pharmaceutical products:
None